海翔药业
(002099)
| 流通市值：83.69亿 | | | 总市值：83.85亿 |
| 流通股本：16.16亿 | | | 总股本：16.19亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,742,822,399.47 | 1,517,014,309.02 | 1,476,603,702.63 | 1,488,185,947.95 |
| 应收票据及应收账款 | 458,417,672.11 | 418,667,299.07 | 368,435,006.58 | 471,863,478.32 |
| 应收账款 | 458,417,672.11 | 418,667,299.07 | 368,435,006.58 | 471,863,478.32 |
| 应收款项融资 | 30,772,951.32 | 41,419,885.26 | 21,637,257.75 | 19,838,878.44 |
| 预付款项 | 29,925,426.5 | 17,200,008.34 | 53,713,839.74 | 29,634,366 |
| 其他应收款合计 | 7,260,994.9 | 7,006,375.6 | 11,483,114.71 | 10,665,128.64 |
| 存货 | 795,680,063.01 | 799,713,624.29 | 800,680,210.22 | 724,050,424.58 |
| 其他流动资产 | 39,232,502.46 | 44,700,670.6 | 41,816,789.07 | 30,397,594.64 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,123,540,366.39 | 2,890,751,484.57 | 2,775,226,104.05 | 2,839,434,160.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 146,189,901.19 | 147,307,716.54 | 159,741,558.17 | 161,534,639.57 |
| 其他权益工具投资 | 27,527,774.69 | 27,527,774.69 | 23,680,709.25 | 23,680,709.25 |
| 其他非流动金融资产 | 463,600,000 | 463,600,000 | 481,319,980.6 | 481,319,980.6 |
| 投资性房地产 | 5,265,716.17 | 5,548,632.13 | 5,831,548.09 | 6,114,464.05 |
| 固定资产 | 2,415,959,006.05 | 2,383,946,659.79 | 2,430,890,751.62 | 2,503,194,797.69 |
| 在建工程 | 448,864,493.77 | 564,581,570.99 | 552,199,663.53 | 430,245,958.9 |
| 使用权资产 | 10,918,722.16 | 12,146,843.11 | 11,267,825.31 | 12,877,024.85 |
| 无形资产 | 515,483,529.61 | 520,433,176.26 | 525,369,225.41 | 529,737,726.85 |
| 商誉 | 394,839,561.58 | 394,839,561.58 | 603,314,115.69 | 603,314,115.69 |
| 长期待摊费用 | 2,632,118.85 | 2,803,738.14 | 3,402,411.91 | 3,303,580.09 |
| 递延所得税资产 | 36,921,005.95 | 42,556,948.57 | 37,686,966.53 | 37,309,122.54 |
| 其他非流动资产 | 1,200,000 | - | - | - |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,469,401,830.02 | 4,565,292,621.8 | 4,834,704,756.11 | 4,792,632,120.08 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,592,942,196.41 | 7,456,044,106.37 | 7,609,930,860.16 | 7,632,066,280.66 |
| 流动负债: | | | | |
| 短期借款 | 1,516,387,512.53 | 1,221,884,861.11 | 1,094,868,055.55 | 1,165,686,416.67 |
| 交易性金融负债 | 4,511,500 | 6,115,500 | 7,083,613.52 | 2,682,000 |
| 应付票据及应付账款 | 722,184,852.34 | 862,095,665.99 | 829,643,402.57 | 694,703,042.94 |
| 其中：应付票据 | 137,276,022.88 | 281,224,364.84 | 239,998,846.96 | 61,475,326 |
| 应付账款 | 584,908,829.46 | 580,871,301.15 | 589,644,555.61 | 633,227,716.94 |
| 合同负债 | 13,922,574.85 | 12,666,650.35 | 12,352,732.19 | 14,539,581.24 |
| 应付职工薪酬 | 35,162,917.38 | 52,323,868.5 | 40,646,874.86 | 38,389,289.64 |
| 应交税费 | 24,269,140.65 | 32,665,989.98 | 20,894,850.43 | 26,174,990.53 |
| 其他应付款合计 | 38,676,416.37 | 34,199,069.86 | 33,186,233.65 | 37,805,678.98 |
| 应付股利 | 2,051,370.43 | 2,051,370.43 | 2,051,370.43 | 2,051,370.43 |
| 一年内到期的非流动负债 | 5,321,013.81 | 5,257,722.11 | 14,199,934.06 | 14,199,934.06 |
| 其他流动负债 | 1,816,505.55 | 1,085,060.74 | 1,179,332.36 | 1,881,461.4 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,362,252,433.48 | 2,228,294,388.64 | 2,054,055,029.19 | 1,996,062,395.46 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 50,000,000 |
| 租赁负债 | 6,357,922.35 | 6,623,499.9 | 7,852,910.05 | 8,463,712.25 |
| 预计负债 | 1,333,333 | 1,333,333 | 2,661,686.02 | 2,661,686.02 |
| 递延收益 | 51,720,624.04 | 54,396,158.17 | 53,383,680.94 | 53,432,884.92 |
| 递延所得税负债 | 31,133,925.05 | 33,566,203.29 | 31,442,134.1 | 34,425,775.89 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 90,545,804.44 | 95,919,194.36 | 95,340,411.11 | 148,984,059.08 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,452,798,237.92 | 2,324,213,583 | 2,149,395,440.3 | 2,145,046,454.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,618,715,253 | 1,618,715,253 | 1,618,715,253 | 1,618,715,253 |
| 资本公积 | 2,916,856,390.48 | 2,916,856,390.48 | 2,906,279,032.74 | 2,906,279,032.74 |
| 减:库存股 | 151,419,651.94 | 151,419,651.94 | 151,419,651.94 | 151,419,651.94 |
| 其他综合收益 | 5,780,417.27 | 5,780,417.27 | 1,951,474.33 | 1,951,474.33 |
| 盈余公积 | 273,932,413.71 | 273,932,413.71 | 262,906,627.77 | 262,906,627.77 |
| 未分配利润 | 484,436,871.62 | 475,206,929.21 | 828,479,667.18 | 854,602,405.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,148,301,694.14 | 5,139,071,751.73 | 5,466,912,403.08 | 5,493,035,141.84 |
| 少数股东权益 | -8,157,735.65 | -7,241,228.36 | -6,376,983.22 | -6,015,315.72 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,140,143,958.49 | 5,131,830,523.37 | 5,460,535,419.86 | 5,487,019,826.12 |
| 负债和股东权益合计 | 7,592,942,196.41 | 7,456,044,106.37 | 7,609,930,860.16 | 7,632,066,280.66 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |